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Abstract
Dyskeratosis congenita (DC) is a rare bone marrow failure syndrome in which hematopoietic defects are the main cause of
mortality. The most studied gene responsible for DC pathogenesis is DKC1 while mutations in several other genes encoding
components of the H/ACA RNP telomerase complex, which is involved in ribosomal RNA(rRNA) processing and telomere
maintenance, have also been implicated. GAR1/nola1 is one of the four core proteins of the H/ACA RNP complex. Through
comparative analysis of morpholino oligonucleotide induced knockdown of dkc1 and a retrovirus insertion induced
mutation of GAR1/nola1 in zebrafish, we demonstrate that hematopoietic defects are specifically recapitulated in these
models and that these defects are significantly reduced in a p53 null mutant background. We further show that changes in
telomerase activity are undetectable at the early stages of DC pathogenesis but rRNA processing is clearly defective. Our
data therefore support a model that deficiency in dkc1 and nola1 in the H/ACA RNP complex likely contributes to the
hematopoietic phenotype through p53 activation associated with rRNA processing defects rather than telomerase
deficiency during the initial stage of DC pathogenesis.
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Introduction
Dyskeratosis congenita (DC) is a rare bone marrow failure
syndrome associated with abnormal skin pigmentation, nail
dystrophy, mucosal leukoplakia, pulmonary fibrosis, and an
increased susceptibility to both hematopoietic and solid cancers
[1]. 85% of DC patients experience bone marrow failure that
accounts for 80% of all DC-related mortality [2]. Discovery that
the telomerase complex gene DKC1 was mutated in a subset of DC
patients provided the first insight into a potential mechanism [3,4].
DKC1 encodes dyskerin, a pseudouridine synthase that com-
plexes with box H/ACA small nuclear RNAs involved in
posttranscriptional modification of ribosomal RNA (rRNA)
through conversion of uridine (U) to pseudouridine (Y). Mutations
in the catalytic domain of dyskerin lead to Hoyeraal-Hreidarsson
syndrome resulting in a severe form of DC including immunode-
ficiency, growth retardation, and microcephaly. Dyskerin is also
associated with the RNA component of telomerase that contains
an H/ACA RNA motif.
Telomerase is a multimeric ribonucleoprotein complex respon-
sible for maintaining telomere length in cells whose incomplete
lagging strand synthesis and oxidative DNA damage result in
progressive shortening of replicated DNA. Telomere shortening is
associated with aging and genomic instability whose impact is
widespread-healthy individuals with shorter telomeres possess a
higher lifetime incidence of cancers [5] and shortened telomeres
are associated with diverse pathologies including psychiatric disease
[6], cardiovascular disease [7], idiopathic pulmonary fibrosis [8],
and diabetes [9].
The telomerase complex consists of the transcriptase subunit
TERT, the rRNA pseudouridylation dyskerin subunit adjoined to
NOP10, NHP2, and GAR1, and the hTR rRNA (encoded by
TERC) providing the template for reverse transcription. The
telomere elongation and replication process is then continued by
the shelterin complex.
At present, approximately 50% of DC patients have an
identified mutation in one of eight genes involved in the
telomerase complex [DKC1, TERC (encoding hTR), TERT,
NHP2, NOP10], the Cajal body localizing co-factor TCAB1
[10,11], the relatively unknown gene C16orf57 [12], or the
shelterin complex (TINF2) [13].
NOLA1 encodes GAR1p, a small nucleolar ribonucleic protein
(snoRNP) that is critical for yeast 18 S rRNA maturation [14] and
pseudouridylation of other precursor rRNAs [15]. It forms a
complex with DKC1, NHP2, and NOP10; however, there are no
reported NOLA1 mutations in any human patients to date.
Whereas knockdown of telomerase complex genes DKC1 and
NOP10 result in a subsequent decrease in TERC expression,
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suggesting that its critical role in rRNA maturation may involve
non-telomerase complex associations.
Despite the clear association between DC patients and
shortened telomere lengths, it remains unclear if shortened
telomeres are the sole driver behind the disease phenotype. DC
patients with DKC1 and TINF2 mutations typically present at
younger ages and with more physical exam abnormalities than
patients with TERC or TERT mutations yet there is no difference
in telomere lengths between these subgroups [17]. Recently a
subset of six DC patients harboring mutations in C16orf57 all had
normal telomere lengths despite severe disease penetrance at a
young age [12]. It is therefore possible that other pathways aside
from telomere maintenance are responsible for the disease
phenotype.
Other bone marrow failure syndromes such as Diamond
Blackfan Anemia(DBA) have been associated with p53 pathway
activation [18]. Up-regulation of p53 has been reported in Dkc1-
deficient mouse hepatocytes [19], suggesting that p53 may be
involved in the pathogenesis of DC as well.
We utilized a morpholino oligonucleotide (MO) knockdown
approach to study the mechanism(s) by which the DC-associated
gene DKC1 results in hematopoietic stem cell failure. To further
understand H/ACA RNPs complex interactions and its role in
DC-related hematopoietic failure we also took advantage of a
retroviral insertional mutation of nola1. We report that both
models result in reduced hematopoiesis, increased p53 expression,
and defective ribosomal biogenesis all without detectable changes
in telomerase function. These data suggest involvement of a
telomerase-independent mechanism by which hematopoietic
failure manifests in dyskeratosis congenita patients.
Results
Dkc1 morphant and nola1 mutant show similar
morphological abnormalities
To study the function of dkc1 during embryonic zebrafish
development we conducted a knockdown experiment with a
splicing morpholino targeting the border between exon 4 and
intron 4. This morpholino is predicted to cause inclusion of the
1.5 kb fourth intron into the mRNA transcript resulting in a
truncated protein due to a pre-mature stop codon. Using primers
spanning exons 4 and 6, morphants demonstrated a 1.5 kb larger
dkc1 transcript with correctly spliced dkc1 transcript reduced to
10% of wild type levels (Fig. 1A b and c). These data demonstrate
efficient knockdown of dkc1. From 3 days post-fertilization (dpf),
dkc1 morphants started to exhibit smaller heads and eyes, fail to
develop the swim bladder, and develop edema (Fig. 1A e and g).
Morphants died around 7 dpf.
We identified a zebrafish line (PKU #13771) carrying a pro-
viral DNA integration in the first exon of nola1 through a
retrovirus insertion screen [20]. Protein sequence homology
alignment revealed that GAR1/nola1 is highly conserved among
different species and human GAR1 and zebrafish nola1 protein
sequences share 81.1% similarity and 79.0% identity. Genomic
synteny relationship analysis also suggested that zebrafish nola1 is
the ortholog of the human GAR1 (Fig.S2 A and B). Zebrafish nola1
is ubiquitously expressed in most cells during early stages of
development starting at 2 hours post-fertilization (hpf). Afterwards,
nola1 is mainly expressed in the brain and intestinal organs
(Fig.S1). Homozygous nola1 mutants shared similar morphologic
changes with dkc1 morphants (Fig. 1B b and d) and mutants died at
7 to 10 days post-fertilization (dpf). Genotyping confirmed that all
embryos with the mutant phenotype were homozygous for the
retroviral insertion (data not shown). Real time quantitative PCR
(qPCR) demonstrated greater than 90% reduction in nola1 mRNA
expression in homozygous mutants (Fig. 1B g). The mutant
phenotype was rescued by injection of nola1 mRNA or GAR1
mRNA (Fig. 1B f and Fig.S2C c), demonstrating the functional
conservation of GAR1/nola1. Overall, functional studies of dkc1
and nola1, two components of the H/ACA RNP complex,
established that their functions were essential for zebrafish larval
development and their deficiencies caused similar morphologic
abnormalities.
Both dkc1 morphants and nola1 mutants have
hematopoietic defects
To determine if dkc1 and nola1 deficiencies in zebrafish would
cause hematopoietic defects similar to DC patients, we analyzed
multiple markers of primitive and definitive hematopoiesis by
RNA whole-mount in situ hybridization. Prior to 3 dpf, no
difference in circulation and hemoglobin staining was detected
between dkc1 morphants, nola1 mutants and their wild type siblings
(data not shown). Additionally, only minimal reduction in
expression of the hematopoietic markers scl and lmo2 was seen in
nola1 mutants at 24 hpf (data not shown). These data suggest that
primitive hematopoiesis is, at most, minimally affected by dkc1 or
nola1 deficiency.
However, expression of definitive hematopoietic stem cell
(HSC) markers runx1 and c-myb were significantly reduced in both
dkc1 and nola1 deficient fish at 30 hpf and 3 dpf, respectively
(Fig. 2A, Fig. 2B a, b, c and d). Nola1 mutants also had greatly
decreased hemoglobin as shown by o-dianisidine staining after
4 dpf (Fig. 2B i and j). This reduction persisted until 7 dpf (data
not shown), indicating that the decrease in red blood cells was not
caused by a delay of development. The decreased number of red
blood cells may be due to the decreased production and/or
decreased cell survival in definitive HSCs.
To explore whether nola1 mutation resulted in reduced
development in all definitive blood lineages, we examined
granulocyte and lymphocyte development using mpx and rag1
expression, respectively. Compared with wild type siblings,
mutants’ lymphoid cells were absent at day 4 (Fig. 2Be–2Bf9). In
contrast, mutants had minimal change in the granulocyte marker
mpx at 3 dpf (Fig. 2Bg–2Bh). These data indicate that definitive
hematopoiesis is compromised to varying degrees by decreased
nola1 expression.
In conclusion, similar to what is observed in human DC
patients, the deficiencies of dkc1 and nola1 in zebrafish result in
defective hematopoiesis. We therefore view these zebrafish as
potential models for DC.
Hematopoietic reduction is mediated by p53
The p53 pathway is activated in some animal models of
congenital hematopoietic diseases, including zebrafish model of
Diamond Blackfan Anemia (DBA) [18]. The p53 network is also
activated in telomerase deficient zebrafish [21]. However, the
mechanism responsible for regulation of hematopoiesis by the p53
pathway is not clear. Our qPCR results showed p53 expression
was increased greater than 4 fold in dkc1 morphants and nola1
mutants. P53 downstream genes such as the pro-apoptotic gene
bax and the cell cycle regulator gene cyclin G1 also had significantly
increased expression (Fig. 3A, C) suggesting that the p53 pathway
is activated with the H/ACA RNPs complex deficiency.
To determine if p53 inhibition could rescue the hematopoietic
defects seen in our models, we microinjected p53 morpholino
(blocking ATG translation) into dkc1 morphants. Although the
inhibition of p53 did not rescue the morphological abnormalities
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and runx1 expression in dkc1 morphants (Fig. 3B). In a different
experiment, we crossed p53 null fish (tp53
M13K) with nola1 mutant
fish and tested interaction of these two genes in a stable genetic
mutant background. Detection of hemoglobin by the o-dianisidine
staining on embryos of p53
+/+ nola1
+/?; p53
+/+ nola1
2/2; p53
2/2
nola1
+/?; p53
2/2 nola1
2/2 showedthat the anemia observed innola1
mutants was rescued in the p53 null background (Fig. 3D, arrows).
Similarly, geneticmutation of p53partially rescued c-myb expression
(Fig.S3). Overall, our data suggest that the hematopoietic defects in
dkc1 morphants and nola1 mutants are p53-dependent. The p53
pathway may function in hematopoiesis by regulating the apoptosis
and cell cycle of HSC and the differentiation of blood cell lineages.
No telomerase activity defects are observed in dkc1 and
nola1 deficient embryos but rRNA processing is inhibited
H/ACA RNP complex functions in both rRNA pseudouridylation
and telomere maintenance [22]. To determine which function of H/
ACA RNP complex plays a more important role in the initiation of
hematopoietic failure in DC, we measured the telomerase activity
and rRNA processing in both dkc1 and nola1 deficient fish.
Figure 1. Molecular and phenotype analysis of dkc1 morphant and nola1 retroviral insertion mutatant of zebrafish. (A) Splicing MO
targeting dkc1 sequence caused the inclusion of intron 4 into mRNA (a). Semi-quantitive PCR data showed an increase of 1.5 kb in the PCR product in
dkc1 morphants (b). According to Real Time PCR result, expression of dkc1 was diminished by more than 90% when high dose (15 ng) of MO was
injected (c). Pictures of embryos at 3 dpf (d and e) and 5 dpf (f and g) showed smaller eyes and smaller head (red arrows in d, e, f and g)i ndkc1
morphants. Compared to wild type embryos, dkc1 morphantsdeveloped edema, andhadfewer red blood cells (red arrowhead in d, e, f andg). d andf:
wild type controls; e andg: dkc1 morphants. (B) A retroviral insertion in exon1 of the nola1 gene led to the phenotype of smaller eyes, smaller head, and
cardiac edema in nola1 homozygous mutant. Red arrow indicated the smaller eyes and smaller head, and red arrowhead showed edema in nola1
homozygous mutant at 3 dpf (a and b) and5 dpf (c and d). Microinjection of nola1 mRNA (f), but not eGFP mRNA (e) can rescue the mutant phenotype
of nola1 homozygous mutants at 5 dpf (red arrow and arrowhead in e and f). a and c: wild type siblings; b, d, e and f: nola1 homozygous mutants.
Expression of nola1 was reduced more than 90% in nola1 homozygous mutants (g). All the pictures of embryos are lateral view with anterior to the left.
doi:10.1371/journal.pone.0030188.g001
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telomerase activity between morphants, mutants, and wild-type
siblings at 3 dpf (Fig. 4Aa, b). To exclude the possibility of HSC-
specific telomerase defects, we injected dkc1 MO into one-cell
stage of Tg(c-myb:GFP) fish embryos, FACS sorted the GFP
positive cells, and measured their telomerase activity. No
difference in telomerase activity was detected in sorted cells
(Fig. 4Ac), suggesting that the hematopoietic failure seen in
mutants/morphants is independent of telomerase function.
However, production of 18 S rRNA was defective in dkc1
morphants at 48 hpf (Fig. 4Ba, b, arrow in a) prior to observation
of the morphologic phenotype. In addition, nola1 mutants showed
Figure 2. Analysis of hematopoietic defects in dkc1 and nola1 deficiency. (A) Expression of HSC marker genes was decreased in dkc1
morphants. C-myb expression at 3 dpf (a and b); runx1 expression at 30 hpf (c and d). (B) Number of HSC (a, b, c and d) and red blood cells (red arrow
in i and j) at 4 dpf were significantly reduced in nola1 mutants. C-myb expression at 3 dpf; runx1 expression at 30 hpf. Granulocytes, marked by mpx,
weren’t affected or slightly less in nola1 mutants at 3 dpf (g and h), while expression of rag1, a marker of lymphoid cells, almost disappeared in nola1
mutants at 4 dpf (red arrow in e–f9). A a–d, B a–d, e, f, g and h are lateral view with anterior to the left, e9 and f9 are dorsal view with anterior to the
left, and i and j are ventral view with anterior to the left.
doi:10.1371/journal.pone.0030188.g002
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(Fig. 4B-c, d, arrow in c). There was no statistically significant
change in production of 28 S rRNA. We obtained the same results
from Northern blotting analysis using probes that were specifically
designed to detect the internally transcribed sequence 1 (ITS1),
internally transcribed sequence 2 (ITS2), and 18 S rRNA.
Decrease of the rRNA precursor generating 18 S rRNA was
observed in the lanes probed with ITS1 in both of dkc1 morphant
at 48 hpf and nola1 mutant at 3 dpf compared with the wild type
controls (arrows in Fig. S4B). Importantly, a significant reduction
of total amount of 18 S rRNA was detected in the lanes probed
with 18 S rRNA in both models. However, no significant
difference was revealed in the lanes probes with ITS2, indicating
that the processing of 28 S rRNA and 5.8 S rRNA appears to be
normal or much less affected. Taken together, our data suggest
that defects in rRNA processing, and not telomerase activity, may
play the central role in DC patients’ bone marrow failure.
Discussion
The goal of this study is to reveal the cause of bone marrow
failure in DC. The prevailing view is that DC is caused by
telomere maintenance defects [23]. Indeed, mutations of several
components of telomerase and shelterin complexes have been
found in DC patients and in many cases telomere shortening is
reported. However, not all data fit this notion. DKC1, NOP10,
and NHP2 are involved not only in telomere maintenance but
are also components of the H/ACA RNP complex. This
conserved complex also performs site-specific pseudouridylation
of ribosomal RNAs [24]. In a Dkc1-dificent mouse model,
deregulation of ribosomal function and hematopoietic defects
have been observed in early development while telomere
shortening has been detected only in later generations [25].
Defects of rRNA maturation in a Drosophila mutant for an
ortholog of this gene have also been reported [26]. In mouse
Dkc1-deficient hepatocytes, accumulation of rRNA precursors
and induction of p53 pathway have been found [19]. P53-
independent cell cycle arrest of cells depleted with dyskerin was
also noted [27]. Based on findings described here, we believe
that defects of ribosome biogenesis constitute an early event in
the pathogenesis of DC and may be the major cause of bone
marrow failure in this disease, although we cannot exclude the
possibility that telomere shortening may contribute to DC at
later stages. Our results agree with studies of Dkc1 mutant mice,
which suggested that deregulated ribosome function is impor-
tant for the initiation of DC [25]. These data may be relevant to
some clinical cases of DC characterized by normal telomeres
[28].
Figure 3. Activation of p53 pathway and rescue of hematopoietic defects in zebrafish dkc1 and nola1 deficiency. (A) and (C) Expression
of genes of p53 pathway was up-regulated in both dkc1 morphant (A) and nola1 mutant (C). Expression level of wild type embryos of related genes
was normalized as 1.0. (B) Knockdown of p53 by injection of p53 MO rescued the reduction of HSC in dkc1 morphants (compare c with e, d with f).
C-myb expression at 3 dpf (a, c and e); runx1 expression at 30 hpf (b, d and f). (D) Red blood cells were restored in nola1 and p53 double mutatant
embryos (red arrow in a–d). 25 embryos at 4 dpf were examined for each group. And the results shown here were representative for three
independent experiments.
doi:10.1371/journal.pone.0030188.g003
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genes on hematopoiesis is mediated by p53. Defects in HSC
development in dkc1 and nola1-deficient zebrafish can be lessened
by p53 inhibition. Zebrafish mutant for nola1 has a phenotype
similar to dkc1 morphant including hematopoietic defects.
Deficiency of both proteins results in p53 up-regulation and the
hematopoietic defects are rescued by p53 inhibition. While this
manuscript was in preparation, Pereboom et al reported that
zebrafish mutation of nop10, another component of H/ACA RNP
complex, caused similar p53 dependent phenotype due to RNA
processing defect [29]. Therefore, our data together with previous
reports reveal an important role for p53 activation in mediating
blood specific defects in DC as well as related diseases such as
DBA [18]. Therapeutics targeting p53 activation may have
beneficial effects in treating these types of diseases.
Notably, mutations of GAR1/nola1 have not been reported in
DC patients [16]. Earlier studies showed that H/ACA snoRNA
accumulation did not require GAR1 [14,30,31]. However, recent
data revealed a crucial role of Gar1/nola1 in the formation of
functional H/ACA RNPs. First, Dyskerin forms a complex with
Figure 4. Analysis of telomere maintenance and rRNA processing in zebrafish dkc1 and nola1 defeicency. (A) TRAP Assay results showed
no difference between dkc1 morphants, nola1 mutants and control embryos at 3 dpf when the mutant phenotype onset (a and b). (c) We injected
dkc1 MO into Tg(c-myb:GFP) fish. GFP-positive HSC were isolated by cell sorting (FACS) at 3 dpf. GFP positive (GFP+) and negative (GFP2) cells from
control embryos (0n gM O ) and dkc1 morphants (15 ng MO) were subjected to TRAP Assay. IC: Internal control; -ctrl: only lysis buffer but no
embryo extracts added group. (B)Analysis of RNA processing showed that reduction of 18 S rRNA in dkc1 morphant (a and b) at 48 hpf and in nola1
mutant (c and d) at 3 dpf, but slight change or no change of 28 S rRNA. The average fold changes of percentage of 18 S rRNA and 28 S rRNA are
represented by the bar graphs. WT: wild type control; MO: dkc1 morphant; nola12/2: nola1 mutant. ** indicates very significant changes at
p,0.01, and * indicates significant changes at p,0.05 on the basis of independent Student t tests.
doi:10.1371/journal.pone.0030188.g004
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precursor of H/ACA RNA to form inactive pre-H/ACA RNPs,
which still lacks Gar1 [24]. The last step of H/ACA RNP
assembly is the replacement of Naf1 with Gar1, which controls the
transition from inactive pre-RNP to functional H/ACA RNP.
Gar1/nola1 is highly conserved among species as illustrated by a
successfully partial rescue of our zebrafish nola1 mutant phenotype
by injection of human GAR1 mRNA. Given the key role of Gar1 in
H/ACA RNPs function, it is possible that its deficiency leads to
early developmental defects such that GAR1-deficient human
embryos do not survive in uteri. This situation may resemble the
case of Diamond Blackfan Anemia. 9 ribosomal proteins have
been found mutated in DBA. What is interesting that mutations in
ribosomal proteins important for ribosomal biogenesis at early
stages (such as RPS11), have never been found in humans
presumably because their deficiency leads to severe defects
incompatible with development. RPS19, most frequently mutated
in DBA patients is involved in ribosome biogenesis only at later
stages and its deficiency causes less damage. Yet zebrafish mutants
for RPS11 and similar RPs have been recovered and their
phenotypes are similar to mutants for RPs mutated in DBA. It
may be that zebrafish embryos are more viable than mammalian
embryos and may therefore provide models that cannot be created
in mammalian species.
In the future, GAR1 should be taken into consideration for DC
cases without mutations in the genes reported.
Materials and Methods
Ethics Statement
All animal experiments were approved by Institutional Animal
Care and Use Committee (IACUC) of Peking University. The
reference from IACUC of Peking University is LSC-ZhangB-1.
Zebrafish Lines
Zebrafish (Danio rerio) were raised and maintained under
standard laboratory conditions [32,33]. Wild type fish lines were
AB or Tuebingen (TU). Nola1 mutant fish line was identified from
an insertional retrovirus mutagenesis screen [20]. P53 null fish
were as described previously [34]. Transgenic fish Tg(c-myb:GFP)
was generated by injecting a BAC construct containing c-myb
regulatory sequences modified with GFP into one-cell stage wild
type embryos. Founders and homozygous F1 were screened for
GFP expression.
Microinjection of morpholino oligonucleotides and
mRNAs
Sequence of splicing dkc1 MO (Gene Tools, Corvallis, OR, USA):
59-GTTAATCCAAGACTTCATACCTGAC-39. P53 ATG MO
was described previously [35]. Sequences of primers used for
detecting the knockdown of dkc1 in morphants are: dkc1RTF1: 59-
GAACATCAGGACGGCTCATT-39 and dkc1RTR1: 59-ATGC-
CCACATACTCTTTGCC-39.
To make mRNA, coding sequences of GAR1 and nola1 were
PCR amplified and cloned into the pCS2+ vector. mRNA were
synthesized by in vitro transcription using mMESSAGE mMA-
CHINEH SP6 Kit (Ambion) according to the manufacturer’s
instructions. Sequences of primers for cloning the coding
sequences of GAR1 and nola1 are: GAR1 RTF: 59-CGGGATCC-
CACGGCTCAGCGTCAGGCAA-39 and GAR1 RTR: 59-CCG-
CTCGAGAGCACCCACAGAGTGCCAGG-39; nola1 RTF2: 59-
CGGGATCCGCACGTGTGGTTCAGAGTCA-39 and nola1
RTR2: 59-CCGCTCGAGTCCATGGTGGCAGCTGGAGT-39.
RNA isolation, reverse transcription and Real Time PCR
Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA,
USA) from 30–40 embryos according to the manufacturer’s
instructions. cDNA was synthesized by reverse transcription using
2 ug RNA with Oligo(dT)12–18 (Invitrogen, Carlsbad, CA,USA).
Real Time PCR was conducted using FastStart Universal SYBR
Green Master (Roche, Diagnostics, Indianapolis, IN, USA) and a
MyiQ Single-Color PCR thermal cycler (Biorad, Hercules, CA,
USA). Each experiment was performed in triplicate and was
repeated three times. Real Time PCR primers used for p53
signaling pathway were described previously [36]. Sequences of
Real Time PCR primers for dkc1 and nola1 were: dkc1RTF1: 59-
GAACATCAGGACGGCTCATT-39 and dkc1RTR1: 59-ATG-
CCCACATACTCTTTGCC-39; nola1 RTF1: 59-AGGAGGCA-
GAGGTGGATTTA-39 and nola1 RTR1: 59-CCCAGTGCGA-
CAACATATTC-39. Dkc1 and nola1 mRNA expression were
normalized to b-actin using the method described previously [37]
and compared to wild-type siblings.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as described
[38] using c-myb, runx1, mpx, rag1 [36] and nola1 riboprobes.
Sequences of primers used for nola1 probe synthesis were:
nola1pRTF: 59-GCACGTGTGGTTCAGAGTCA-39 and no-
la1pRTR: 59-ACGGAGCTGCCCAAAGAT-39. Runx1 expres-
sion analysis in nola1 mutation was performed at 30 hpf. At this
stage, the mutants were not distinguishable from wild type
according to the morphology. After in situ hybridization, ,25%
(12/50) embryos exhibited the reduction of runx1 shown as in
figure 2 Bd, and ,75% (38/50) showed the normal pattern as seen
in figure 2 Bc. We confirmed those having expression shown in
figure 2 Bd as nola1 mutants and those in figure 2 Bc as wild type
or heterozygous by PCR genotyping.
Whole-mount o-dianisidine staining
Hemoglobin was detected by whole-mount o-dianisidine
staining as described previously [36]. Briefly, 25 embryos under
anesthesia were stained in o-dianisidine solution [(0.6 mg/ml o-
dianisidine, 0.01 M sodium acetate (pH 4.5), 0.65% hydrogen
peroxide, 40% ethanol)] for 15 min in the dark followed by two
washes with PBS.
Isolation of hematopoietic stem cells and FACS analysis
300 transgenic zebrafish embryos expressing GFP under c-myb
promoter were dechorionated with protease at 3 days post
fertilization (dpf) and washes with Ca
2+ free Ringer’s solution for
15 min. Embryos were incubated with 0.25% Trypsin-EDTA at 28
degrees Celsius for 30–50 min and then centrifuged at 300 g for
5 min. Cells were washed once with suspension solution [Leibovitz
medium L-15, 0.8 Mm CaCl2, 1% FBS] and then resuspended in
suspension solution. Suspension was filtered through a mesh capped
tube. FACS sorting was performed with a flow cytometer sorter (BD
AriaII). GFP positive and negative cells were sorted out.
In vitro measurement of telomerase activity
The TRAPezeH telomerase detection kit (Millipore) was used
according to the manufacturer’s instructions. The PCR products
were separated with 10% polyacrylamide gels and visualized by
ethidium bromide staining.
Analysis of RNA processing
RNA was isolated from 30 embryos at different stages (24 hpf,
48 hpf and 3 dpf) using Trizol (Invitrogen, Carlsbad, CA,USA)
The Effects of nola1 and dck1 Loss in Zebrafish
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CA, USA) according to the manufacturer’s instructions. RNA
samples were analyzed using Agilent RNA 6000 Nano Kit
(Agilent, Waldbronn, Germany) according to the manufacturer’s
instructions.
Northern blotting analysis
Total RNA was isolated from 50 embryos at 48 hpf for dkc1 or
3 dpf for nola1 using Trizol (Invitrogen, Carlsbad, CA, USA) and
cleaned up with Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA,
USA) according to the manufacturer’s instructions. Northern blots
were operated as previously described [39]. Total RNA (1.0 mg
per lane) was separated by electrophoresis on a 2% formaldehyde,
1.2% agarose gel and blotted onto a nylon membrane (Hybond-N,
Amersham Biosciences). RNA blots were cross linked to the
membrane by UV irradiation and probed with DIG labeled ITS1,
ITS2 and 18 S rRNA probes using prehybridization and
hybridization solution (Roche, Diagnostics, Indianapolis, IN,
USA) at 65uC. The intensity of staining relative to the background
was measured using ImageJ program.
Supporting Information
Figure S1 Temporal and spatial expression pattern of
nola1. (A) Semi-quantitative PCR result showed that nola1 was
expressed from about 2 hpf. (B) Non-specific expression of nola1
was detected during the early stage of zebrafish development
(a, b). Afterward, nola1 expression was mainly detected in the
brain and some inner organs. a: nola1 expression at 7 hpf; b: nola1
expression at 10 hpf; c and c9: nola1 expression at 4 dpf. a, b:
lateral view; c: lateral view with anterior to the left; c9: dorsal view
with anterior to the left.
(TIF)
Figure S2 Nola1 is highly conserved among different
species. (A) Analysis result using Clustal W software showed
protein sequences of nola1 from different species have high
similarity. (B) Synteny analysis data show the evolutionary
conservation of nola1.( C) Microinjection of GAR1 mRNA can
partially rescue the mutant phenotype of nola1 homozygous
mutants at 5 dpf (red arrow and arrowhead in a, b and c). a:
wild type sibling; b: nola1 homozygous mutant; c: nola1
homozygous mutant injected with human GAR1 mRNA. All of
the pictures of embryos are lateral view with anterior to the left.
(TIF)
Figure S3 Rescue of hematopoietic defects of nola1
mutant in p53 mutant background. (A) p53
+/+ nola1
+/?;( B)
p53
+/+ nola1
2/2;( C) p53
2/2 nola1
2/2. Number of HSC (marked
by c-myb, red arrows) was partially rescued in nola1 and p53 double
mutant at 3 dpf.
(TIF)
Figure S4 Deficiencies of both dkc1 and nola1 lead to
the defects of rRNA processing. (A) Schematic figure
modified from previous report [29] shows the overview of rRNA
processing. (B) A significant decrease of a precursor strand
generating ITS1 and 18 S rRNA was detected in the lanes probed
with ITS1 in both dkc1 morphant and nola1 mutant compared with
wild type controls (arrows in a and b). The total amount of 18 S
rRNA was reduced significantly as shown in the lanes probed with
18 S rRNA probe. The intensity of staining of 18 S rRNA relative
to the background was measured using ImageJ program. In
contrast, no obvious difference was detected in the lanes probed
with ITS2 probe.
(TIF)
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